Austarpharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUSTARPHARMA, and what generic and branded alternatives to AUSTARPHARMA drugs are available?
AUSTARPHARMA has five approved drugs.
Drugs and US Patents for Austarpharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Austarpharma | FENOFIBRATE | fenofibrate | TABLET;ORAL | 208476-002 | Feb 10, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 210281-001 | May 20, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | FENOFIBRATE | fenofibrate | TABLET;ORAL | 207803-001 | Dec 19, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | TADALAFIL | tadalafil | TABLET;ORAL | 208824-002 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | TADALAFIL | tadalafil | TABLET;ORAL | 208824-003 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | TADALAFIL | tadalafil | TABLET;ORAL | 208824-001 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Austarpharma | FENOFIBRATE | fenofibrate | TABLET;ORAL | 207803-002 | Dec 19, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.